JCR Pharmaceuticals Cash Flow Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	-6,414	7,244	5,412	19,404	8,653
Depreciation & Amortization	3,374	3,197	1,997	1,945	1,892
Loss (Gain) on Equity Investments	467	1,090	-	-	-
Other Operating Activities	-2,276	1,982	-8,280	-2,520	-801
Change in Accounts Receivable	2,698	-3,797	4,448	-7,402	-205
Change in Inventory	-822	-2,437	-3,877	-1,082	-4,699
Change in Accounts Payable	-2,003	1,854	-2,892	1,305	2,630
Change in Other Net Operating Assets	-510	179	-2,308	-2,361	2,871
Operating Cash Flow	-5,486	9,312	-5,500	9,289	10,341
Operating Cash Flow Growth	-	-	-	-10.17%	109.88%
Capital Expenditures	-9,888	-1,526	-7,654	-11,333	-4,780
Cash Acquisitions	-	-600	-6,717	-	-
Divestitures	145	-	-	-	-
Sale (Purchase) of Intangibles	-	-569	-906	-	-2,747
Investment in Securities	-	-	259	-	193
Other Investing Activities	-131	5	16	8,083	4,044
Investing Cash Flow	-9,874	-2,690	-15,002	-3,250	-3,290
Short-Term Debt Issued	14,805	-	3,000	-	8,320
Long-Term Debt Issued	750	9,600	4,750	750	1,750
Total Debt Issued	15,555	9,600	7,750	750	10,070
Short-Term Debt Repaid	-	-6,900	-	-	-
Long-Term Debt Repaid	-750	-2,200	-3,050	-750	-650
Total Debt Repaid	-750	-9,100	-3,050	-750	-650
Net Debt Issued (Repaid)	14,805	500	4,700	-	9,420
Issuance of Common Stock	21	-	-	-	-
Repurchase of Common Stock	-2,530	15	10	10	13
Common Dividends Paid	-2,505	-2,500	-2,739	-2,169	-1,083
Other Financing Activities	-55	-46	-23	-20	-46
Financing Cash Flow	9,736	-2,031	1,948	-2,179	8,304
Foreign Exchange Rate Adjustments	64	886	1,099	612	-22
Miscellaneous Cash Flow Adjustments	1	-	1	-	-1
Net Cash Flow	-5,559	5,477	-17,454	4,472	15,332
Free Cash Flow	-15,374	7,786	-13,154	-2,044	5,561
Free Cash Flow Growth	-	-	-	-	6148.32%
Free Cash Flow Margin	-46.49%	18.16%	-38.30%	-4.00%	18.48%
Free Cash Flow Per Share	-124.16	62.09	-105.37	-16.46	44.80
Cash Interest Paid	147	87	46	45	46
Cash Income Tax Paid	2,284	-1,982	8,279	2,517	807
Levered Free Cash Flow	-13,174	4,178	-15,235	4,843	5,053
Unlevered Free Cash Flow	-13,077	4,232	-15,207	4,871	5,080
Change in Working Capital	-637	-4,201	-4,629	-9,540	597

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.